|
Award for Excellence in
TB Reporting Instituted
The institution of a new journalism prize, ‘the Stop TB Partnership/
Lilly MDR-TB Partnership Journalism Award’ was announced on the eve (8
to 12 November 2007) of the World Conference of the International Union
against Tuberculosis and Lung Disease.
The award, which will be granted for the first time in 2008, will
recognize outstanding reporting and commentary in print and on the web
that materially increases the public's knowledge and understanding of
tuberculosis (TB) and multi-drug-resistant TB (MDR-TB), in countries
affected by the disease.
The winners of the 2008 award will be announced on the occasion of the
World Conference of the International Union Against Tuberculosis and
Lung Diseases in November 2008. The deadline for entries for the 2008
award is April 30, 2008.
Dr Marcos Espinal, Executive Secretary of the Stop TB Partnership said:
"We view this award as a means to foster high-quality journalism in
countries where reliable information about TB and the fight against this
deadly disease is most sorely needed”.
Eligible articles must have been published between March 1, 2007 and
March 31,
2008 in a general circulation newspaper, magazine or web news vehicle
located in a low or middle-income country (based on World Bank income
criteria: World Bank Country Classification).
There will be second and third place awards as well. The first place
award will be 3000 USD, second place 2000 USD and third place 1000 USD.
The articles may be co-authored, and author(s) must reside in the
country where the article was published. An independent jury of experts
will make the selections. The Stop TB Partnership will administer all
aspects of the award.
"The Stop TB/Lilly MDR-TB Partnership Journalism Award, rewarding
excellence in reporting on the topic of tuberculosis and multidrug-resistant
tuberculosis, does many things. It helps raise awareness surrounding
these diseases, including their causes and prevalence and helps mobilize
communities into immediate action," said Patrizia Carlevaro, Head of the
International Aid Unit, Eli Lilly and Company.
The Stop TB Partnership, which is hosted by the World Health
Organization in Geneva, Switzerland, is a network of more then 500
international organizations, countries, donors from the public and
private sectors, and nongovernmental and governmental organizations that
are working together to eliminate TB.
The Lilly MDR-TB Partnership is a public-private initiative that
encompasses global health and relief organizations, academic
institutions and private companies and is led by Eli Lilly and Company.
Its mission is to address the expanding crisis of multi-drug resistant
tuberculosis (MDR-TB). The partnership is pursuing a comprehensive
strategy to fight MDR-TB through increasing drug supply at concessionary
prices; research; providing training in prevention, treatment, and
surveillance; promoting awareness and community support programs and
sharing drug manufacturing technology with nations most at risk of MDR-TB.
Further information on the award can be obtained from Judith
Mandelbaum-Schmid, Communications Officer, Stop TB Partnership, Email:
schmidj@who.int
|
